Mylan clears extra $164M in profit from EpiPen that CEO didn't disclose to Congress
Monday, September 26, 2016 - 15:31
in Mathematics & Economics
Doug G. WareCANONSBURG, Pa., Sept. 26 (UPI) -- Drug maker Mylan admitted its top executive was only partly truthful last week when telling Congress how much profit it takes from each EpiPen sold.